You have 9 free searches left this month | for more free features.

cutaneous T-cell lymphoma (CTCL)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Skin Barrier and Microbiome of CTCL Patients

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
    • Leiden, Netherlands
      Centre for Human Drug Research
    Apr 21, 2023

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • (no location specified)
    Dec 7, 2022

    Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))

    Recruiting
    • Cutaneous T Cell Lymphoma
    • Micro needle array-Doxorubicin (MNA-D)
    • Pittsburgh, Pennsylvania
      University Of Pittsburgh Medical Center
    Jun 2, 2022

    Cutaneous T-cell Lymphoma Retreated With Brentuximab Vedotin

    Not yet recruiting
    • T-Cell Lymphoma
    • No intervention
    • Bordeaux, France
    • +10 more
    May 24, 2023

    Cutaneous T-cell Lymphoma (CTCL) Trial in United Kingdom (CDK-003)

    Recruiting
    • Cutaneous T-cell Lymphoma (CTCL)
    • CDK-003
    • Birmingham, United Kingdom
    • +3 more
    Apr 22, 2022

    Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

    Active, not recruiting
    • Lymphoma, T-Cell, Cutaneous
    • Mycosis Fungoides/Sezary Syndrome
    • Madrid, Spain
    • +1 more
    Jul 1, 2022

    Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

    Recruiting
    • Advanced Solid Tumor
    • Cutaneous T-cell Lymphoma (CTCL)
    • Detroit, Michigan
    • +5 more
    Oct 6, 2022

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Trial in Bordeaux, Paris (chlormethine gel)

      Recruiting
      • Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
      • chlormethine gel
      • Bordeaux, France
      • +1 more
      Aug 17, 2022

      Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin, Mechlorethamine Topical Gel)

      Not yet recruiting
      • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
      • Fairport, New York
        Rochester Skin Lymphoma Medical Group
      Nov 20, 2023

      Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford, Chicago, Houston (Sapacitabine)

      Terminated
      • Cutaneous T-cell Lymphoma (CTCL)
      • Stanford, California
      • +2 more
      Dec 7, 2021

      Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

      Recruiting
      • Mantle Cell Lymphoma
      • +9 more
      • L-Bcl-2 antisense oligonucleotide
      • Augusta, Georgia
      • +2 more
      Nov 18, 2022

      CTCL Trial in New Haven (ABT-199 (venetoclax))

      Completed
      • CTCL
      • ABT-199 (venetoclax)
      • New Haven, Connecticut
        Yale New Haven Hospital / Smilow Cancer Center
      Jun 22, 2021

      Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the

      Recruiting
      • Cutaneous T Cell Lymphoma
      • Mycosis Fungoides
      • UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
      • THERAKOS® CELLEX photopheresis system
      • New York, New York
        Herbert Irving Pavilion
      Dec 23, 2022

      Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)

      Active, not recruiting
      • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
      • Yamagata, Japan
        Yamagata University Hospital
      Feb 21, 2022

      BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Marseille (L19IL2/L19TNF)

      Not yet recruiting
      • BCC - Basal Cell Carcinoma
      • +6 more
      • Marseille, France
        Hôpital de la Timone
      Jun 22, 2022

      Cutaneous T-Cell Lymphoma, Relapsed, Cutaneous T-Cell Lymphoma Refractory Trial in Worldwide (Mogamulizumab)

      Recruiting
      • Cutaneous T-Cell Lymphoma, Relapsed
      • Cutaneous T-Cell Lymphoma Refractory
      • Duarte, California
      • +17 more
      Jul 19, 2022

      T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

      Completed
      • T-Cell Lymphoma Relapsed
      • +4 more
      • IL-15 plus
      • alemtuzumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 27, 2022

      Tissue Repository: CTCL Collection Protocol

      Recruiting
      • Lymphoma, T-Cell, Cutaneous
      • +2 more
        • New York, New York
          Columbia University Medical Center
        May 2, 2022

        Diagnostic Classifier for Cutaneous T-cell Lymphomas

        Recruiting
        • CTCL/ Mycosis Fungoides
        • Skin suction blistering and skin biopsies
        • Vienna, Austria
          Medical University of Vienna
        Apr 4, 2022

        Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

        Active, not recruiting
        • Folliculotropic Mycosis Fungoides
        • +7 more
        • Extracorporeal Photopheresis
        • +3 more
        • Duarte, California
          City of Hope Medical Center
        Dec 8, 2022

        Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Gdansk (WP1220)

        Completed
        • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
        • Gdansk, Poland
          Medical University of Gdansk
        Jan 8, 2021

        Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

        Terminated
        • Mycosis Fungoides
        • +2 more
        • Naloxone Hydrochloride Lotion, 0.5%
        • Placebo Lotion
        • Little Rock, Arkansas
        • +15 more
        Oct 26, 2022

        Cutaneous T-Cell Lymphoma Trial in United States (Panobinostat)

        Terminated
        • Cutaneous T-Cell Lymphoma
        • Birmingham, Alabama
        • +17 more
        Aug 16, 2021